title: Preliminary results of laparoscopic modified radical hysterectomy in early invasive cervical cancer.
abstract: OBJECTIVE
  To compare laparoscopic modified radical hysterectomy (LMRH) with traditional modified radical hysterectomy (MRH) in women with early invasive cervical cancer.
  
  
  METHODS
  Prospective, nonrandomized study (Canadian Task Force classification II-1).
  
  
  METHODS
  Chi Mei Foundation Medical Center, Tainan, Taiwan.
  
  
  METHODS
  Ten women with cervical cancer stage Ia2 to Ib1 (</=2 cm). Intervention. LMRH (class II radical hysterectomy) and pelvic lymphadenectomy.
  
  
  RESULTS
  The pathologist examined all specimens. The width of parametrium (mean +/- SD) was 1.75 +/- 0.68 cm on the right and 1.70 +/- 0.54 cm on the left. The length of the vaginal cuff was 1.37 +/- 0.86 cm. Operating time for LMRH (159 +/- 26.4 min) was similar to that for MRH (165.7 +/- 30.5 min). Postoperative hospitalization for LMRH (4.1 +/- 1.5 days) and estimated blood loss (250 +/- 147.2 ml) were significantly less than for MRH (8.3 +/- 4.4 days and 611.5 +/- 256.8 ml, respectively). No intraoperative complications occurred, and no patient experienced postoperative voiding dysfunction or constipation.
  
  
  CONCLUSIONS
  Based on preliminary results, LMRH is feasible for treatment of early invasive cervical cancer, and may become preferred for surgical staging of the disease.
authors.affiliation: Department of Obstetrics and Gynecology, Chi Mei Foundation Medical Center, No. 901, Chung Hwa Road, Yung Kang City, Tainan, Taiwan.
authors.forename: Yue-Shan
authors.initials: YS
authors.lastname: Lin
mesh_terms: D000328:Adult; D000368:Aged; D001707:Biopsy, Needle; D002294:Carcinoma, Squamous Cell / Q000473:pathology* / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects / Q000379:methods*; D010535:Laparoscopy / Q000009:adverse effects / Q000379:methods*; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009367:Neoplasm Staging; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000473:pathology* / Q000601:surgery*